Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture

Details for Australian Patent Application No. 2001271481 (hide)

Owner Lenaerts, V. Beck, R. Bogaert, E. Chouinard, F. Hopcke, R. Desevaux, C.

Inventors Desevaux, Cyril; Lenaerts, Vincent; Beck, Roland Herwig Friedrich; Bogaert, Elsie Van; Chouinard, Francois; Hopcke, Reiner

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001271481

PCT Pub. Number WO02/02084

Priority 09606399 29.06.00 US

Filing date 26 June 2001

Wipo publication date 14 January 2002

Acceptance publication date 26 May 2005

International Classifications

A61K 009/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

26 May 2005 Application Accepted

  Published as AU-B-2001271481

22 September 2005 Standard Patent Sealed

21 August 2008 Assignment Registered

  Lenaerts, Vincent; Herwig Friedrich Beck, Roland; Van Bogaert, Elsie; Chouinard, Francois; Hopcke, Reiner; Desevaux, Cyril The patent has been assigned to Labopharm (Barbados) Limited; Labopharm Europe Limited

11 September 2008 Assignment Registered

  Labopharm Europe Limited; Labopharm (Barbados) Limited The patent has been assigned to Labopharm Europe Limited; Labopharm (Barbados) Limited; Labopharm Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001271482

2001271480-Systems and methods for assessing and modifying an individual's physiological condition